FTC Action Stops Unsupported Claims for Opiate Withdrawal Treatments

A company that marketed itself as “the leader in home opiate detox since 2009” and its CEO have settled Federal Trade Commission charges that the withdrawal treatment claims for their “Withdrawal Ease” and “Recovery Ease” products were false or unsupported by scientific evidence. The court order settling the FTC’s charges bars Catlin Enterprises, Inc. and […]